- Home
- BNGO vs ACXP Comparison
BNGO vs ACXP Comparison
Compare BNGO & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNGO
- ACXP
- Stock Information
- Founded
- BNGO 2003
- ACXP 2017
- Country
- BNGO United States
- ACXP United States
- Employees
- BNGO N/A
- ACXP N/A
- Industry
- BNGO Biotechnology: Laboratory Analytical Instruments
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- BNGO Industrials
- ACXP Health Care
- Exchange
- BNGO Nasdaq
- ACXP Nasdaq
- Market Cap
- BNGO 28.7M
- ACXP 31.4M
- IPO Year
- BNGO 2018
- ACXP 2021
- Fundamental
- Price
- BNGO $0.21
- ACXP $1.30
- Analyst Decision
- BNGO Hold
- ACXP Strong Buy
- Analyst Count
- BNGO 3
- ACXP 1
- Target Price
- BNGO $1.00
- ACXP $12.00
- AVG Volume (30 Days)
- BNGO 3.5M
- ACXP 97.1K
- Earning Date
- BNGO 11-13-2024
- ACXP 11-12-2024
- Dividend Yield
- BNGO N/A
- ACXP N/A
- EPS Growth
- BNGO N/A
- ACXP N/A
- EPS
- BNGO N/A
- ACXP N/A
- Revenue
- BNGO $33,334,000.00
- ACXP N/A
- Revenue This Year
- BNGO N/A
- ACXP N/A
- Revenue Next Year
- BNGO $21.35
- ACXP N/A
- P/E Ratio
- BNGO N/A
- ACXP N/A
- Revenue Growth
- BNGO N/A
- ACXP N/A
- 52 Week Low
- BNGO $0.20
- ACXP $1.18
- 52 Week High
- BNGO $2.27
- ACXP $5.28
- Technical
- Relative Strength Index (RSI)
- BNGO 24.89
- ACXP 12.41
- Support Level
- BNGO $0.27
- ACXP $1.18
- Resistance Level
- BNGO $0.38
- ACXP $1.73
- Average True Range (ATR)
- BNGO 0.02
- ACXP 0.12
- MACD
- BNGO -0.00
- ACXP -0.05
- Stochastic Oscillator
- BNGO 0.00
- ACXP 16.67
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.